Related Experiment Video
Updated: Jun 23, 2026
16:40
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
A 59-year-old man considering implantation of a cardiac defibrillator
1Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. pzimetba@bidmc.harvard.edu
JAMA
|May 3, 2007
Summary
Sudden cardiac death affects many Americans yearly. Implantable cardioverter-defibrillators can prevent this, but patients and doctors must weigh device benefits against risks like recalls.
Area of Science:
- Cardiology
- Medical Devices
Background:
- Sudden cardiac death (SCD) is a significant cause of mortality, with nearly 450,000 deaths annually in the US.
- Patients with a history of myocardial infarction (MI) and left ventricular dysfunction face a high risk of sudden arrhythmic death.
Observation:
- Implantable cardioverter-defibrillators (ICDs) are effective in reducing SCD risk and are increasingly used in high-risk patients.
- A case study highlights the considerations for prophylactic ICD implantation, including patient concerns about device recalls and malfunctions.
Findings:
- The decision for primary prevention of SCD with an ICD requires careful evaluation of individual patient risk.
- Balancing the life-saving potential of ICDs against potential device-related issues is crucial for informed patient-physician decision-making.
Implications:
- Enhanced patient education and transparent communication regarding ICD benefits and risks are essential.
- Further research into device reliability and patient-specific risk stratification can optimize the use of ICDs for primary SCD prevention.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:23Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...